Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Bonesupport AB and Signus Medical LLC sign distribution agreement for the U.S. market


2007-01-29 -- The Swedish medical technology company, Bonesupport, in Lund, which develops synthetic, injectable ceramic bone substitute, has signed its first commercial distribution agreement in North America. The agreement with the American company Signus Medical LLC covers exclusive sales rights in ten key states and is an important breakthrough in the U.S. market.

The agreement is of strategic importance to BONESUPPORT with the imminent launch of the first product CERAMENT™|BONE VOID FILLER in the North American market. The product is used for filling bone voids in the skeleton during treatment of bone defects and osteoporotic fractures. The first delivery has already been shipped and will be used primarily for clinical marketing and demonstration of the CERAMENT™ concept.

− Signus Medical and the medical technology and segments which they focus on compliment Bonesupport well and will enable us to grow in the American market. With the coming U.S. launch of our first product, CERAMENT™|BONE VOID FILLER, we are entering a new and exciting phase with our first commercial agreement completed and our first sales invoiced, says Fredrik Lindberg, CEO at Bonesupport.

The American market is the worlds biggest and the agreement means that Bonesupport now has qualified access to ten key states with the potential for further expansion in the future.. CERAMENT™|BONE VOID FILLER will initially be used in the spine segment with other broader orthopaedic applications being added successively.

The market potential for the injectible bone substitute CERAMENT™ is large worldwide. The global orthopaedic market turns over billions of dollars annuallly and within five years it is estimated that the potential market for treatment of vertebral fractures will be valued at more than two billion dollars in the USA alone. Annual growth is projected to be about 50 percent.. CERAMENT™|BONE VOID FILLER will address the growing needs of doctors for a synthetic alternative for the treatment of bone defects and osteoporotic fractures.

Signus Medical LLC is a privately held, high growth medical technology company with its headquarters in Chanhassen, Minnesota. Founded on the principle of being a rapid response conduit to the spine market; flexibility and innovation are the cornerstones of success and direction for the future. They are constantly seeking out unique materials and products to provide superior solutions to address the challenges faced by today’s surgeons.


− Bonesupport’s CERAMENT™|BONE VOID FILLER is a fantastic addition to our product portfolio and will further enable Signus Medical’s continued expansion in the American market, says Thomas Hoghaug,CEO Signus Medical LLC. CERAMENT™ has all of the distinctive characteristics which we look for to allow for specific differentiation from other products on the market.

The launch of CERAMENT™|BONE VOID FILLER begins with joint activities at the worlds biggest orthopaedics congresss, American Academy of Orthopaedic Surgeons 2007 (AAOS) in San Diego in February.

For further information contact:
Fredrik Lindberg, CEO, BONESUPPORT AB
Tel. +46 46-286 53 79 or 0708-86 53 70
Ian Kirkwood, Director Int. Marketing & Sales, BONESUPPORT AB
Tel. +46 46-286 53 58 or 0706-16 53 58

Thomas Hoghaug, CEO, Signus Medical, LLC
Tel. +1-952-294-8700

Don Kennedy, VP Sales and Marketing, Signus Medical, LLC
Tel. +1-952-294-8730

www.bonesupport.com
www.signusmedical.com


About Bonesupport
Bonesupports products are primarily aimed at patients with osteoporosis, a condition which affects every second woman and every fourth man over 50 years old. The company’s first product - Cerament™ Bone Void Filler – is currently being introduced into the U.S. market.


About Signus Medical LLC
Founded in 2001, Signus Medical, LLC is an innovaative developer of medical devices specifically targeted at the spinal market. Initially built on the premise of filling product line v


Publisher Contact Information:

BoneSupport AB
+46 4628 65379
info@bonesupport.com

Company profile of BoneSupport AB
Past press releases of BoneSupport AB.

Data


26,442
Tech investments
From our Online Data Service
17,073
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 6€9.3MSoftware development
Dec 6€1.5MConsumer applications
Dec 6€3.7MInternet commerce
Dec 5€8.0MNanotechnology
Dec 5€11.0MBiotechnology
Dec 5€11.0MRobotics
Dec 5N/ARobotics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.